In vivo genetic profiling and cellular localization of apelin reveals a hypoxia-sensitive, endothelial-centered pathway activated in ischemic heart failure
- 1 January 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 294 (1) , H88-H98
- https://doi.org/10.1152/ajpheart.00935.2007
Abstract
Signaling by the peptide ligand apelin and its cognate G protein-coupled receptor APJ has a potent inotropic effect on cardiac contractility and modulates systemic vascular resistance through nitric oxide-dependent signaling. In addition, there is evidence for counterregulation of the angiotensin and vasopressin pathways. Regulatory stimuli of the apelin-APJ pathway are of obvious importance but remain to be elucidated. To better understand the physiological response of apelin-APJ to disease states such as heart failure and to elucidate the mechanism by which such a response might occur, we have used the murine model of left anterior descending coronary artery ligation-induced ischemic cardiac failure. To identify the key cells responsible for modulation and production of apelin in vivo, we have created a novel apelin-lacZ reporter mouse. Data from these studies demonstrate that apelin and APJ are upregulated in the heart and skeletal muscle following myocardial injury and suggest that apelin expression remains restricted to the endothelium. In cardiac failure, endothelial apelin expression correlates with other hypoxia-responsive genes, and in healthy animals both apelin and APJ are markedly upregulated in various tissues following systemic hypoxic exposure. Experiments with cultured endothelial cells in vitro show apelin mRNA and protein levels to be increased by hypoxia, through a hypoxia-inducible factor-mediated pathway. These studies suggest that apelin-expressing endothelial cells respond to conditions associated with heart failure, possibly including local tissue hypoxia, and modulate apelin-APJ expression to regulate cardiovascular homeostasis. The apelin-APJ pathway may thus provide a mechanism for systemic endothelial monitoring of tissue perfusion and adaptive regulation of cardiovascular function.Keywords
This publication has 39 references indexed in Scilit:
- Impaired Heart Contractility in Apelin Gene–Deficient Mice Associated With Aging and Pressure OverloadCirculation Research, 2007
- The G Protein-Coupled Receptor Agtrl1b Regulates Early Development of Myocardial ProgenitorsDevelopmental Cell, 2007
- Apelin and Its Receptor Control Heart Field Formation during Zebrafish GastrulationDevelopmental Cell, 2007
- Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expressionCellular & Molecular Biology Letters, 2007
- Opposing cardiovascular roles for the angiotensin and apelin signaling pathwaysJournal of Molecular and Cellular Cardiology, 2006
- Down-regulation of cardiac apelin system in hypertrophied and failing hearts: Possible role of angiotensin II–angiotensin type 1 receptor systemJournal of Molecular and Cellular Cardiology, 2006
- Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryoDevelopmental Biology, 2006
- Apelin is a novel angiogenic factor in retinal endothelial cellsBiochemical and Biophysical Research Communications, 2004
- Regulatory Roles for APJ, a Seven-transmembrane Receptor Related to Angiotensin-type 1 Receptor in Blood Pressure in VivoJournal of Biological Chemistry, 2004
- Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ ReceptorBiochemical and Biophysical Research Communications, 1998